News
14 Apr 2023
Important new results from EORTC to be presented at ESTRO 2023
22 Feb 2023
HMP Global and EORTC announce partnership for the 25th annual World Congress on Gastrointestinal Cancer
31 Jan 2023
First international recommendations on the use of item libraries for patient-reported outcome measurement
30 Jan 2023
FDA Approves KEYTRUDA® (pembrolizumab) as Adjuvant Treatment Following Surgical Resection and Platinum-Based Chemotherapy for Patients with Stage IB (T2a ≥4 Centimeters), II, or IIIA Non-Small Cell Lung Cancer (NSCLC)
19 Dec 2022
Completion of Patient Recruitment for International TIGER Study
12 Dec 2022
Brain Tumour Group,Breast Cancer Group,Head and Neck Cancer Group,Lung Cancer Group,News,Radiation Oncology Group
EORTC, CTI, and IRROG collaboration opens new opportunities in Ireland
2 Dec 2022
EORTC, SPO and AICIB establish a partnership to promote cancer clinical research in Portugal
29 Nov 2022
Stakeholders’ consensus response to the proposed European Health Data Space
25 Nov 2022
Concepts assessed in the EORTC QLQ-C30 questionnaire are important and relevant for patients with cancer
17 Nov 2022
EORTC and KHCC sign first Middle Eastern collaboration agreement
